Sfoglia per Autore
Low Serum 25(OH)D Levels in Parkinson âÂÂs Disease; a Non Specific Marker of Neurodegeneration?
2015-01-01 Olivola, E; Rocco, C; Conti, M; Pierantozzi, M; Liguori, C; Stefani, A
Commentary: Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease
2015-01-01 Liguori, C; Pierantozzi, M; Olivola, E; Mercuri, Nb; Stefani, A
Catecholamine-based treatment in AD patients: expectations and delusions
2015-01-01 Stefani, A; Olivola, E; Liguori, C; Hainsworth, A; Saviozzi, V; Angileri, G; D'Angelo, V; Galati, S; Pierantozzi, M
Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a natural population of cognitive intact Parkinson's Disease patients.
2017-12-01 Liguori, C; Olivola, E; Pierantozzi, M; Cerroni, R; Galati, S; Saviozzi, V; Mercuri, Nb; Stefani, A
Does fatigue in Parkinson’s disease correlate with autonomic nervous system dysfunction?
2018-01-01 Olivola, E; Brusa, L; Rocchi, C; Schillaci, O; Liguori, C; Cerroni, R; Pierantozzi, M; Chiaravalloti, A; Stefani, A; Stocchi, F
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study
2019-01-01 Liguori, C; Ruffini, R; Olivola, E; Chiaravalloti, A; Izzi, F; Stefani, A; Pierantozzi, M; Mercuri, Nb; Modugno, N; Centonze, D; Schillaci, O; Placidi, F
Daytime sleepiness may be an independent symptom unrelated to sleep quality in Parkinson’s disease
2019-01-01 Liguori, C; Mercuri, Nb; Albanese, M; Olivola, E; Stefani, A; Pierantozzi, M
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study
2019-03-23 Liguori, C; Ruffini, R; Olivola, E; Chiaravalloti, A; Izzi, F; Stefani, A; Pierantozzi, M; Mercuri, Nb; Modugno, N; Centonze, D; Schillaci, O; Placidi, F
Continuous subcutaneous apomorphine infusion in Parkinson’s disease: causes of discontinuation and subsequent treatment strategies
2019-05-20 Olivola, E; Fasano, A; Varanese, S; Lena, F; Santilli, M; Femiano, C; Centonze, D; Modugno, N
Correction to: Continuous subcutaneous apomorphine infusion in Parkinson’s disease: causes of discontinuation and subsequent treatment strategies (Neurological Sciences, (2019), 40, 9, (1917-1923), 10.1007/s10072-019-03920-5)
2019-07-01 Olivola, E; Fasano, A; Varanese, S; Lena, F; Santilli, M; Femiano, C; Centonze, D; Modugno, N
Validation of the Italian version of the PSP Quality of Life questionnaire
2019-11-01 Picillo, M; Cuoco, S; Amboni, M; Bonifacio, F; Bruschi, F; Carotenuto, I; De Micco, R; De Rosa, A; Del Prete, E; Di Biasio, F; Elifani, F; Erro, R; Fabbri, M; Falla, M; Franco, G; Frosini, D; Galantucci, S; Lazzeri, G; Magistrelli, L; Malaguti, M; Milner, A; Minafra, B; Olivola, E; Pilotto, A; Rascunà, C; Rizzetti, M; Schirinzi, T; Borroni, B; Ceravolo, R; Di Fonzo, A; Marchese, R; Mercuri, N; Modugno, N; Nicoletti, A; Padovani, A; Santangelo, G; Stefani, A; Tessitore, A; Volontè, M; Zangaglia, R; Zappia, M; Zibetti, M; Barone, P
An attempt to dissect a peripheral marker based on cell pathology in Parkinson's disease
2021-01-01 Biagioni, F; Ferese, R; Giorgi, Fs; Modugno, N; Olivola, E; Lenzi, P; Gambardella, S; Centonze, D; Ruggieri, S; Fornai, F
Effects of prismatic lenses on lateral axial dystonia in Parkinson's disease: a pilot study
2021-01-01 Meglio, M; Olivola, E; Santilli, M; Lena, F; Centonze, D; Bologna, M; Modugno, N
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2015 | Low Serum 25(OH)D Levels in Parkinson âÂÂs Disease; a Non Specific Marker of Neurodegeneration? | Olivola, E; Rocco, C; Conti, M; Pierantozzi, M; Liguori, C; Stefani, A | Articolo su rivista | |
| 1-gen-2015 | Commentary: Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease | Liguori, C; Pierantozzi, M; Olivola, E; Mercuri, Nb; Stefani, A | Articolo su rivista | |
| 1-gen-2015 | Catecholamine-based treatment in AD patients: expectations and delusions | Stefani, A; Olivola, E; Liguori, C; Hainsworth, A; Saviozzi, V; Angileri, G; D'Angelo, V; Galati, S; Pierantozzi, M | Articolo su rivista | |
| 1-dic-2017 | Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a natural population of cognitive intact Parkinson's Disease patients. | Liguori, C; Olivola, E; Pierantozzi, M; Cerroni, R; Galati, S; Saviozzi, V; Mercuri, Nb; Stefani, A | Articolo su rivista | |
| 1-gen-2018 | Does fatigue in Parkinson’s disease correlate with autonomic nervous system dysfunction? | Olivola, E; Brusa, L; Rocchi, C; Schillaci, O; Liguori, C; Cerroni, R; Pierantozzi, M; Chiaravalloti, A; Stefani, A; Stocchi, F | Articolo su rivista | |
| 1-gen-2019 | Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study | Liguori, C; Ruffini, R; Olivola, E; Chiaravalloti, A; Izzi, F; Stefani, A; Pierantozzi, M; Mercuri, Nb; Modugno, N; Centonze, D; Schillaci, O; Placidi, F | Articolo su rivista | |
| 1-gen-2019 | Daytime sleepiness may be an independent symptom unrelated to sleep quality in Parkinson’s disease | Liguori, C; Mercuri, Nb; Albanese, M; Olivola, E; Stefani, A; Pierantozzi, M | Articolo su rivista | |
| 23-mar-2019 | Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study | Liguori, C; Ruffini, R; Olivola, E; Chiaravalloti, A; Izzi, F; Stefani, A; Pierantozzi, M; Mercuri, Nb; Modugno, N; Centonze, D; Schillaci, O; Placidi, F | Articolo su rivista | |
| 20-mag-2019 | Continuous subcutaneous apomorphine infusion in Parkinson’s disease: causes of discontinuation and subsequent treatment strategies | Olivola, E; Fasano, A; Varanese, S; Lena, F; Santilli, M; Femiano, C; Centonze, D; Modugno, N | Articolo su rivista | |
| 1-lug-2019 | Correction to: Continuous subcutaneous apomorphine infusion in Parkinson’s disease: causes of discontinuation and subsequent treatment strategies (Neurological Sciences, (2019), 40, 9, (1917-1923), 10.1007/s10072-019-03920-5) | Olivola, E; Fasano, A; Varanese, S; Lena, F; Santilli, M; Femiano, C; Centonze, D; Modugno, N | Articolo su rivista | |
| 1-nov-2019 | Validation of the Italian version of the PSP Quality of Life questionnaire | Picillo, M; Cuoco, S; Amboni, M; Bonifacio, F; Bruschi, F; Carotenuto, I; De Micco, R; De Rosa, A; Del Prete, E; Di Biasio, F; Elifani, F; Erro, R; Fabbri, M; Falla, M; Franco, G; Frosini, D; Galantucci, S; Lazzeri, G; Magistrelli, L; Malaguti, M; Milner, A; Minafra, B; Olivola, E; Pilotto, A; Rascunà, C; Rizzetti, M; Schirinzi, T; Borroni, B; Ceravolo, R; Di Fonzo, A; Marchese, R; Mercuri, N; Modugno, N; Nicoletti, A; Padovani, A; Santangelo, G; Stefani, A; Tessitore, A; Volontè, M; Zangaglia, R; Zappia, M; Zibetti, M; Barone, P | Articolo su rivista | |
| 1-gen-2021 | An attempt to dissect a peripheral marker based on cell pathology in Parkinson's disease | Biagioni, F; Ferese, R; Giorgi, Fs; Modugno, N; Olivola, E; Lenzi, P; Gambardella, S; Centonze, D; Ruggieri, S; Fornai, F | Articolo su rivista | |
| 1-gen-2021 | Effects of prismatic lenses on lateral axial dystonia in Parkinson's disease: a pilot study | Meglio, M; Olivola, E; Santilli, M; Lena, F; Centonze, D; Bologna, M; Modugno, N | Articolo su rivista |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile